Eradication of human immunodeficiency virus from brain reservoirs

Journal of NeuroVirology

Volumn 21, Issue 3, 2015, Pages 227-234

  Nath, Avindra ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Antiretroviral; Astrocyte; Compartmentalization; Latency; Macrophage; Microglia

Indexed keywords

BRAIN; DISEASE CARRIER; HIV INFECTIONS; HUMAN; PHYSIOLOGY; VIROLOGY; VIRUS LATENCY;

BRAIN; DISEASE RESERVOIRS; HIV INFECTIONS; HUMANS; VIRUS LATENCY;

EID: 84939932889     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-014-0291-1     Document Type: Review

References (75)

1. Allers K, Hutter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E et al (2011) Evidence for the cure of HIV infection by CCR5Delta32/Delta32 stem cell transplantation. Blood 117(10):2791–2799
2. Andras IE, Pu H, Deli MA, Nath A, Hennig B, Toborek M (2003) HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res 74(2):255–265
3. Bansal AK, Mactutus CF, Nath A, Maragos W, Hauser KF, Booze RM (2000) Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res 879(1–2):42–49
4. Bechmann I, Priller J, Kovac A, Bontert M, Wehner T, Klett FF et al (2001) Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages. Eur J Neurosci 14(10):1651–1658
5. Bechmann I, Goldmann J, Kovac AD, Kwidzinski E, Simburger E, Naftolin F et al (2005) Circulating monocytic cells infiltrate layers of anterograde axonal degeneration where they transform into microglia. FASEB J 19(6):647–649
6. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H et al (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387(6629):183–188
7. Churchill MJ, Gorry PR, Cowley D, Lal L, Sonza S, Purcell DF et al (2006) Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J Neurovirol 12(2):146–152
8. Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ et al (2009) Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 66(2):253–258
9. Cohen J (2011) Understanding HIV, latency to undo it. Science 332(6031):786
10. Cosenza MA, Zhao ML, Si Q, Lee SC (2002) Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 12(4):442–455
11. Cowley D, Gray LR, Wesselingh SL, Gorry PR, Churchill MJ (2011) Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia. J Neurovirol 17(1):70–81
12. Croteau D, Letendre S, Best BM, Ellis RJ, Breidinger S, Clifford D et al (2010) Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1. Antimicrob Agents Chemother 54(12):5156–5160
13. Dahl V, Lee E, Peterson J, Spudich SS, Leppla I, Sinclair E et al (2011) Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy. J Infect Dis 204(12):1936–1945
14. Davey RT Jr, Bhat N, Yoder C, Chun TW, Metcalf JA, Dewar R et al (1999) HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A 96(26):15109–15114
15. Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C et al (2002) A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy. Mol Ther 5(6):788–797
16. Dunfee RL, Thomas ER, Gorry PR, Wang J, Taylor J, Kunstman K et al (2006) The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc Natl Acad Sci U S A 103(41):15160–15165
17. Ene L, Duiculescu D, Ruta SM (2011) How much do antiretroviral drugs penetrate into the central nervous system? J Med Life 4(4):432–439
18. Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T et al (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5(5):512–517
19. Fischer-Smith T, Bell C, Croul S, Lewis M, Rappaport J (2008) Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J Neurovirol 14(4):318–326
20. Fitting S, Xu R, Bull C, Buch SK, El-Hage N, Nath A et al (2010) Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol 177(3):1397–1410
21. Fujimura RK, Goodkin K, Petito CK, Douyon R, Feaster DJ, Concha M et al (1997) HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia. J Acquir Immune Defic Syndr Hum Retrovirol 16(3):146–152
22. Gonzalez-Perez MP, O’Connell O, Lin R, Sullivan WM, Bell J, Simmonds P et al (2012) Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue. Retrovirology 9:20
23. Gonzalez-Scarano F, Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5(1):69–81
24. Gray LR, Gabuzda D, Cowley D, Ellett A, Chiavaroli L, Wesselingh SL et al (2011) CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates. J Neurovirol 17(1):82–91
25. Gupta RK, Soni N, Kumar S, Khandelwal N (2012) Imaging of central nervous system viral diseases. J Magn Reson Imaging 35(3):477–491
26. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17(1):3–16
27. Ho YC, Shan L, Hosmane NN, Wang J, Laskey SB, Rosenbloom DI et al (2013) Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155(3):540–551
28. Holman AG, Mefford ME, O’Connor N, Gabuzda D (2010) HIVBrainSeqDB: a database of annotated HIV envelope sequences from brain and other anatomical sites. AIDS Res Ther 7:43
29. Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V et al (2010) Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 28(8):839–847
30. Hutter G, Ganepola S (2011) Eradication of HIV by transplantation of CCR5-deficient hematopoietic stem cells. Sci World J 11:1068–1076
31. Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K et al (2009) Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 360(7):692–698
32. Johnson T, Nath A (2011) Immune reconstitution inflammatory syndrome and the central nervous system. Curr Opin Neurol 24(3):284–290
33. Johnson TP, Patel K, Johnson KR, Maric D, Calabresi PA, Hasbun R et al (2013) Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc Natl Acad Sci U S A 110(33):13588–13593
34. Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410(6831):988–994
35. Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell JE, Brack-Werner R (2005) Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 111(2):194–213
36. Lamers SL, Salemi M, Galligan DC, Morris A, Gray R, Fogel G et al (2010) Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. J Neurovirol 16(3):230–241
37. Lamers SL, Poon AF, McGrath MS (2011a) HIV-1 nef protein structures associated with brain infection and dementia pathogenesis. PLoS One 6(2):e16659
38. Lamers SL, Gray RR, Salemi M, Huysentruyt LC, McGrath MS (2011b) HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis 11(1):31–37
39. Lawrence DM, Durham LC, Schwartz L, Seth P, Maric D, Major EO (2004) Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J Virol 78(14):7319–7328
40. Li W, Huang Y, Reid R, Steiner J, Malpica-Llanos T, Darden TA et al (2008) NMDA receptor activation by HIV-Tat protein is clade dependent. J Neurosci Off J Soc Neurosci 28(47):12190–12198
41. Maldarelli F, Palmer S, King MS, Wiegand A, Polis MA, Mican J et al (2007) ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS Pathog 3(4):e46
42. Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K et al (2009) Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 23(11):1359–1366
43. McCarthy GF, Leblond CP (1988) Radioautographic evidence for slow astrocyte turnover and modest oligodendrocyte production in the corpus callosum of adult mice infused with 3H-thymidine. J Comp Neurol 271(4):589–603
44. Mediouni S, Darque A, Baillat G, Ravaux I, Dhiver C, Tissot-Dupont H et al (2012) Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein. Infect Disord Drug Targets 12(1):81–86
45. Mercier F, Kitasako JT, Hatton GI (2002) Anatomy of the brain neurogenic zones revisited: fractones and the fibroblast/macrophage network. J Comp Neurol 451(2):170–188
46. Nath A (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186(Suppl 2):S193–S198
47. Nath A, Hartloper V, Furer M, Fowke KR (1995) Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. J Neuropathol Exp Neurol 54(3):320–330
48. Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47(2):186–194
49. O’Donnell LA, Agrawal A, Jordan-Sciutto KL, Dichter MA, Lynch DR, Kolson DL (2006) Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes. J Neurosci 26(3):981–990
50. Olivieri KC, Agopian KA, Mukerji J, Gabuzda D (2010) Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes. AIDS Res Hum Retrovir 26(4):495–500
51. Palmer S, Maldarelli F, Wiegand A, Bernstein B, Hanna GJ, Brun SC et al (2008) Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A 105(10):3879–3884
52. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, Chen IS (1990) High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 343(6253):85–89
53. Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R et al (1995) Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9(9):1001–1008
54. Sawchuk RJ, Yang Z (1999) Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system. Adv Drug Deliv Rev 39(1–3):5–31
55. Schnell G, Price RW, Swanstrom R, Spudich S (2010) Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol 84(5):2395–2407
56. Schwartz L, Major EO (2006) Neural progenitors and HIV-1-associated central nervous system disease in adults and children. Curr HIV Res 4(3):319–327
57. Schwartz L, Civitello L, Dunn-Pirio A, Ryschkewitsch S, Berry E, Cavert W et al (2007) Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue. J Neurovirol 13(3):274–283
58. Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC et al (2012) Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36(3):491–501
59. Singh IN, Goody RJ, Dean C, Ahmad NM, Lutz SE, Knapp PE et al (2004) Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: differential involvement of caspase-3 and endonuclease G. J Neurovirol 10(3):141–151
60. Stranford SA, Ong JC, Martinez-Marino B, Busch M, Hecht FM, Kahn J et al (2001) Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. Proc Natl Acad Sci U S A 98(2):597–602
61. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD (1996) Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 39(6):705–711
62. Teo I, Veryard C, Barnes H, An SF, Jones M, Lantos PL et al (1997) Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol 71(4):2928–2933
63. Thompson KA, Churchill MJ, Gorry PR, Sterjovski J, Oelrichs RB, Wesselingh SL et al (2004) Astrocyte specific viral strains in HIV dementia. Ann Neurol 56(6):873–877
64. Tornatore C, Nath A, Amemiya K, Major EO (1991) Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 65(11):6094–6100
65. Tornatore C, Chandra R, Berger JR, Major EO (1994) HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44(3 Pt 1):481–487
66. Trillo-Pazos G, Diamanturos A, Rislove L, Menza T, Chao W, Belem P et al (2003) Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 13(2):144–154
67. Vissers M, Stelma FF, Koopmans PP (2010) Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system? J Clin Virol Off Pub Pan Am Soc Clin Virol 49(4):231–238
68. Wang Z, Trillo-Pazos G, Kim SY, Canki M, Morgello S, Sharer LR et al (2004) Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J Neurovirol 10(Suppl 1):25–32
69. Wang T, Lee MH, Choi E, Pardo-Villamizar CA, Lee SB, Yang IH et al (2012) Granzyme B-induced neurotoxicity is mediated via activation of PAR-1 receptor and Kv1.3 channel. PLoS One 7(8):e43950
70. Wiley CA, Soontornniyomkij V, Radhakrishnan L, Masliah E, Mellors J, Hermann SA et al (1998) Distribution of brain HIV load in AIDS. Brain Pathol 8(2):277–284
71. Williams KC, Hickey WF (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 25:537–562
72. Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, de Bakker C et al (2001) Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193(8):905–915
73. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA et al (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278(5341):1291–1295
74. Wu Y, Marsh JW (2001) Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293(5534):1503–1506
75. Zhao L, Galligan DC, Lamers SL, Yu S, Shagrun L, Salemi M et al (2009) High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS. Sci China Ser C Life Sci / Chin Acad Sci 52(7):651–656